Contemporary update on pathology-related issues on routine workup of prostate biopsy sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry

Rodolfo Montironi, Antonio Lopez-Beltran, Roberta Mazzucchelli, Marina Scarpelli, Andrea B. Galosi, Liang Cheng

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

While the prime goal of the needle biopsy is to diagnose prostatic adenocarcinoma (PCa), once PCa is detected further descriptive information regarding the type of cancer, amount of tumor, and grade in prostate needle cores forms the cornerstone for contemporary management of the patient and to assess the potential for local cure and the risk for distant metastasis. This review gives an update on selected pathology-related issues on routine workup of prostate biopsy with special references to adequate histologic sectioning necessary to maximize cancer yield, tumor extent measurements and methodologies, specimen orientation, and the role of immunohistochem-istry in the evaluation of the prostate. Multiple factors influence the diagnostic yield of prostate biopsies. Many of these factors are fixed and uncontrollable. Other factors are controlled by the urologist, including number of cores obtained, method and location of biopsy, and amount of tissue obtained. The yield of cancer is also controlled by the pathologist and histotechnologist. It is necessary to report the number of cores submitted and the number of positive cores, thereby giving the fraction of positive cores. The percentage involvement by carcinoma with or without the linear extent of carcinoma of the single core with the greatest amount of tumor should also be provided. Using the marking technique, we can add a new pathological parameter: pathological orientation. Cancer or atypical lesions can be accurately located within the biopsy specimen and integrated to biopsy approach. Probably the most common use of immunohistochemistry in the evaluation of the prostate is for the identification of basal cells, which are absent with rare exception in adenocarcinoma of the prostate and in general positive in mimickers of prostate cancer. If a case is still considered atypical by a uropathology expert after negative basal cell staining, positive staining for alphamethylacyl-CoA-racemase can help establish in 50% of these cases a definitive diagnosis of cancer.

Original languageEnglish
Pages (from-to)61-70
Number of pages10
JournalAnalytical and Quantitative Cytology and Histology
Volume36
Issue number2
StatePublished - 2014

Fingerprint

Prostate
Immunohistochemistry
Pathology
Biopsy
Neoplasms
Adenocarcinoma
Staining and Labeling
Carcinoma
Racemases and Epimerases
Needle Biopsy
Coenzyme A
Needles
Prostatic Neoplasms
Neoplasm Metastasis

Keywords

  • Active surveillance
  • Histological sectioning
  • Immunohistochemistry
  • Prostate biopsy
  • Prostate cancer
  • Specimen orientation
  • Tumor extent

ASJC Scopus subject areas

  • Anatomy
  • Histology

Cite this

Contemporary update on pathology-related issues on routine workup of prostate biopsy sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry. / Montironi, Rodolfo; Lopez-Beltran, Antonio; Mazzucchelli, Roberta; Scarpelli, Marina; Galosi, Andrea B.; Cheng, Liang.

In: Analytical and Quantitative Cytology and Histology, Vol. 36, No. 2, 2014, p. 61-70.

Research output: Contribution to journalArticle

@article{17a6f272fb2148f9a57f4a4730248561,
title = "Contemporary update on pathology-related issues on routine workup of prostate biopsy sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry",
abstract = "While the prime goal of the needle biopsy is to diagnose prostatic adenocarcinoma (PCa), once PCa is detected further descriptive information regarding the type of cancer, amount of tumor, and grade in prostate needle cores forms the cornerstone for contemporary management of the patient and to assess the potential for local cure and the risk for distant metastasis. This review gives an update on selected pathology-related issues on routine workup of prostate biopsy with special references to adequate histologic sectioning necessary to maximize cancer yield, tumor extent measurements and methodologies, specimen orientation, and the role of immunohistochem-istry in the evaluation of the prostate. Multiple factors influence the diagnostic yield of prostate biopsies. Many of these factors are fixed and uncontrollable. Other factors are controlled by the urologist, including number of cores obtained, method and location of biopsy, and amount of tissue obtained. The yield of cancer is also controlled by the pathologist and histotechnologist. It is necessary to report the number of cores submitted and the number of positive cores, thereby giving the fraction of positive cores. The percentage involvement by carcinoma with or without the linear extent of carcinoma of the single core with the greatest amount of tumor should also be provided. Using the marking technique, we can add a new pathological parameter: pathological orientation. Cancer or atypical lesions can be accurately located within the biopsy specimen and integrated to biopsy approach. Probably the most common use of immunohistochemistry in the evaluation of the prostate is for the identification of basal cells, which are absent with rare exception in adenocarcinoma of the prostate and in general positive in mimickers of prostate cancer. If a case is still considered atypical by a uropathology expert after negative basal cell staining, positive staining for alphamethylacyl-CoA-racemase can help establish in 50{\%} of these cases a definitive diagnosis of cancer.",
keywords = "Active surveillance, Histological sectioning, Immunohistochemistry, Prostate biopsy, Prostate cancer, Specimen orientation, Tumor extent",
author = "Rodolfo Montironi and Antonio Lopez-Beltran and Roberta Mazzucchelli and Marina Scarpelli and Galosi, {Andrea B.} and Liang Cheng",
year = "2014",
language = "English",
volume = "36",
pages = "61--70",
journal = "Analytical and Quantitative Cytopathology and Histopathology",
issn = "0301-102X",
publisher = "John Rylands University Library",
number = "2",

}

TY - JOUR

T1 - Contemporary update on pathology-related issues on routine workup of prostate biopsy sectioning, tumor extent measurement, specimen orientation, and immunohistochemistry

AU - Montironi, Rodolfo

AU - Lopez-Beltran, Antonio

AU - Mazzucchelli, Roberta

AU - Scarpelli, Marina

AU - Galosi, Andrea B.

AU - Cheng, Liang

PY - 2014

Y1 - 2014

N2 - While the prime goal of the needle biopsy is to diagnose prostatic adenocarcinoma (PCa), once PCa is detected further descriptive information regarding the type of cancer, amount of tumor, and grade in prostate needle cores forms the cornerstone for contemporary management of the patient and to assess the potential for local cure and the risk for distant metastasis. This review gives an update on selected pathology-related issues on routine workup of prostate biopsy with special references to adequate histologic sectioning necessary to maximize cancer yield, tumor extent measurements and methodologies, specimen orientation, and the role of immunohistochem-istry in the evaluation of the prostate. Multiple factors influence the diagnostic yield of prostate biopsies. Many of these factors are fixed and uncontrollable. Other factors are controlled by the urologist, including number of cores obtained, method and location of biopsy, and amount of tissue obtained. The yield of cancer is also controlled by the pathologist and histotechnologist. It is necessary to report the number of cores submitted and the number of positive cores, thereby giving the fraction of positive cores. The percentage involvement by carcinoma with or without the linear extent of carcinoma of the single core with the greatest amount of tumor should also be provided. Using the marking technique, we can add a new pathological parameter: pathological orientation. Cancer or atypical lesions can be accurately located within the biopsy specimen and integrated to biopsy approach. Probably the most common use of immunohistochemistry in the evaluation of the prostate is for the identification of basal cells, which are absent with rare exception in adenocarcinoma of the prostate and in general positive in mimickers of prostate cancer. If a case is still considered atypical by a uropathology expert after negative basal cell staining, positive staining for alphamethylacyl-CoA-racemase can help establish in 50% of these cases a definitive diagnosis of cancer.

AB - While the prime goal of the needle biopsy is to diagnose prostatic adenocarcinoma (PCa), once PCa is detected further descriptive information regarding the type of cancer, amount of tumor, and grade in prostate needle cores forms the cornerstone for contemporary management of the patient and to assess the potential for local cure and the risk for distant metastasis. This review gives an update on selected pathology-related issues on routine workup of prostate biopsy with special references to adequate histologic sectioning necessary to maximize cancer yield, tumor extent measurements and methodologies, specimen orientation, and the role of immunohistochem-istry in the evaluation of the prostate. Multiple factors influence the diagnostic yield of prostate biopsies. Many of these factors are fixed and uncontrollable. Other factors are controlled by the urologist, including number of cores obtained, method and location of biopsy, and amount of tissue obtained. The yield of cancer is also controlled by the pathologist and histotechnologist. It is necessary to report the number of cores submitted and the number of positive cores, thereby giving the fraction of positive cores. The percentage involvement by carcinoma with or without the linear extent of carcinoma of the single core with the greatest amount of tumor should also be provided. Using the marking technique, we can add a new pathological parameter: pathological orientation. Cancer or atypical lesions can be accurately located within the biopsy specimen and integrated to biopsy approach. Probably the most common use of immunohistochemistry in the evaluation of the prostate is for the identification of basal cells, which are absent with rare exception in adenocarcinoma of the prostate and in general positive in mimickers of prostate cancer. If a case is still considered atypical by a uropathology expert after negative basal cell staining, positive staining for alphamethylacyl-CoA-racemase can help establish in 50% of these cases a definitive diagnosis of cancer.

KW - Active surveillance

KW - Histological sectioning

KW - Immunohistochemistry

KW - Prostate biopsy

KW - Prostate cancer

KW - Specimen orientation

KW - Tumor extent

UR - http://www.scopus.com/inward/record.url?scp=84903764672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903764672&partnerID=8YFLogxK

M3 - Article

VL - 36

SP - 61

EP - 70

JO - Analytical and Quantitative Cytopathology and Histopathology

JF - Analytical and Quantitative Cytopathology and Histopathology

SN - 0301-102X

IS - 2

ER -